Linked In Blog - Sedgwick
Skip to content

Posts related to ‘pharmeceutical’

Search
Filter
View
Blog
April 05, 2022
Amanda Combs
recall consultant
High levels of nitrosamine causing recalls

Over the past few years, several drugmakers have had to recall blood pressure medications due to the presence of excess levels of nitrosamine. It’s happening again. Two major pharmaceutical companies have issued voluntary recalls of several tablet me…

April 05, 2022 by Amanda Combs, recall consultant
Blog
March 11, 2022
Julie Ross, International business development director and Luke Evans, business development manager
European recalls rose in 2021 despite COVID-19 disruptions

As we enter the third calendar year of the COVID-19 pandemic, regulators are adapting to the “new normal.” As reported in our latest edition of the recall index report, product recalls rose by over a quarter (25.5%) across key European industries in …

March 11, 2022 by Julie Ross, International business development director and Luke Evans, business development manager
Blog
March 04, 2022
Chris Harvey
VP, crisis solution
Recall index sees lingering COVID-19 challenges for all key industries in 2022

While regulators and business leaders enter the third calendar year of COVID-19, some new challenges are emerging atop the lingering supply chain and service issues brought on by the pandemic. The Biden administration continues to push for more consu…

March 04, 2022 by Chris Harvey, VP, crisis solution
Blog
February 16, 2022
Mark Buckingham
recall advisor
New EU Clinical Trial Regulation brings positive and negative changes

The European Union Clinical Trial Regulation (CTR) recently came into force and introduced a unified regulatory regime that applies to all EU member states. While the goal of the CTR is to reestablish the EU’s competitiveness in the field of scientif…

February 16, 2022 by Mark Buckingham, recall advisor
Blog
December 13, 2021
Chris Harvey
VP, crisis solution
Regulatory, legal and reputational risks increasing for all businesses in 2022

We are living through a perfect storm of heightened business risks that are impacting every industry — from labor shortages, supply chain issues and inflation to increased regulatory oversight and enforcement. When combined, these risks pose su…

December 13, 2021 by Chris Harvey, VP, crisis solution
Blog
November 15, 2016
Dr. Teresa Bartlett
managing director, senior medical officer
More bad news about opioids

At Sedgwick, we are committed to steering people away from opioid addiction and finding solutions to returning them back to healthy, productive lives. However, the lure of such drugs can begin even before entering the workforce and experiencing an …

November 15, 2016 by Dr. Teresa Bartlett, managing director, senior medical officer
End of results.
Loading...